
Journal Menu
► ▼ Journal Menu-
- JCM Home
- Aims & Scope
- Editorial Board
- Reviewer Board
- Topical Advisory Panel
- Instructions for Authors
- Special Issues
- Topics
- Sections & Collections
- Article Processing Charge
- Indexing & Archiving
- Editor’s Choice Articles
- Most Cited & Viewed
- Journal Statistics
- Journal History
- Journal Awards
- Society Collaborations
- Conferences
- Editorial Office
Journal Browser
► ▼ Journal BrowserNeed Help?
Announcements
31 May 2024
Meet Us at the FENS Forum 2024, 25–29 June 2024, Vienna, Austria

Conference: FENS Forum 2024
Date: 25–29 June 2024
Location: Vienna, Austria
MDPI will be attending FENS Forum 2024 as an exhibitor; we welcome researchers from different backgrounds to visit and share their latest ideas with us.
This conference has been organized by the Federation of European Neuroscience Societies (FENS), the Austrian Neuroscience Association (ANA) and and the Hungarian Neuroscience Society. The FENS Forum is Europe’s largest neuroscience congress, covering all areas of neuroscience from basic to translational research.
The following MDPI journals will be represented:
- Brain Sciences;
- Journal of Clinical Medicine (JCM);
- Cells;
- NeuroSci;
- Neuroglia;
- Biomedicines;
- Neurology International;
- Behavioral Sciences;
- Psychoactives.
If you are planning on attending this conference, please do not hesitate to contact us. Our delegates look forward to meeting you in person at booth #1003, and answering any questions that you may have. For more information about the conference, please visit the following website: https://www.fens.org/meetings/fens-forum/upcoming-fens-forums.
31 May 2024
Journal of Clinical Medicine | Highly Cited Papers in 2023 and Hot Topic Special Issues on Ophthalmology

We are delighted to share some highly cited papers on ophthalmology that were published in the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) in 2023. In addition, some Special Issues on this topic are currently open for submission.
The following is a list of articles and Special Issues that we believe will interest you:
1. “iERM: An Interpretable Deep Learning System to Classify Epiretinal Membrane for Different Optical Coherence Tomography Devices: A Multi-Center Analysis“
by Kai Jin, Yan Yan, Shuai Wang, Ce Yang, Menglu Chen, Xindi Liu, Hiroto Terasaki, Tun-Hang Yeo, Neha Gulab Singh, Yao Wang et al.
J. Clin. Med. 2023, 12(2), 400; https://doi.org/10.3390/jcm12020400
Available online: https://www.mdpi.com/2077-0383/12/2/400
2. “A No-History Multi-Formula Approach to Improve the IOL Power Calculation after Laser Refractive Surgery: Preliminary Results”
by Ferdinando Cione, Maddalena De Bernardo, Marco Gioia, Marianunzia Oliviero, Andrea Giuseppe Santoro, Alessandro Caputo, Luigi Capasso, Sergio Pagliarulo and Nicola Rosa
J. Clin. Med. 2023, 12(8), 2890; https://doi.org/10.3390/jcm12082890
Available online: https://www.mdpi.com/2077-0383/12/8/2890
3. “Bruch’s Membrane: A Key Consideration with Complement-Based Therapies for Age-Related Macular Degeneration”
by Sarah Hammadi, Nikolaos Tzoumas, Mariantonia Ferrara, Ingrid Porpino Meschede, Katharina Lo, Claire Harris, Majlinda Lako and David H. Steel
J. Clin. Med. 2023, 12(8), 2870; https://doi.org/10.3390/jcm12082870
Available online: https://www.mdpi.com/2077-0383/12/8/2870
4. “Segmentation-Assisted Fully Convolutional Neural Network Enhances Deep Learning Performance to Identify Proliferative Diabetic Retinopathy”
by Minhaj Alam, Emma J. Zhao, Carson K. Lam and Daniel L. Rubin
J. Clin. Med. 2023, 12(1), 385; https://doi.org/10.3390/jcm12010385
Available online: https://www.mdpi.com/2077-0383/12/1/385
5. “Detecting Macular Disease Based on Optical Coherence Tomography Using a Deep Convolutional Network“
by Jinyoung Han, Seong Choi, Ji In Park, Joon Seo Hwang, Jeong Mo Han, Junseo Ko, Jeewoo Yoon and Daniel Duck-Jin Hwang
J. Clin. Med. 2023, 12(3), 1005; https://doi.org/10.3390/jcm12031005
Available online: https://www.mdpi.com/2077-0383/12/3/1005
6. “Three-Month Safety and Efficacy Outcomes for the Smaller-Incision New-Generation Implantable Miniature Telescope (SING IMT™)”
by Mario Damiano Toro, Faustino Vidal-Aroca, Marina Montemagni, Claudio Xompero, Gaetano Fioretto and Ciro Costagliola
J. Clin. Med. 2023, 12(2), 518; https://doi.org/10.3390/jcm12020518
Available online: https://www.mdpi.com/2077-0383/12/2/518
7. “Complement Inhibitors for Advanced Dry Age-Related Macular Degeneration (Geographic Atrophy): Some Light at the End of the Tunnel?”
by Miguel Cruz-Pimentel and Lihteh Wu
J. Clin. Med. 2023, 12(15), 5131; https://doi.org/10.3390/jcm12155131
Available online: https://www.mdpi.com/2077-0383/12/15/5131
8. “Exploring the Relationship between Anti-VEGF Therapy and Glaucoma: Implications for Management Strategies”
by Qëndresë Daka, Nina Špegel, Makedonka Atanasovska Velkovska, Tjaša Steblovnik, Miriam Kolko, Burim Neziri and Barbara Cvenkel
J. Clin. Med. 2023, 12(14), 4674; https://doi.org/10.3390/jcm12144674
Available online: https://www.mdpi.com/2077-0383/12/14/4674
9. “Comparison of Five Presbyopia-Correcting Intraocular Lenses: Optical-Bench Assessment with Visual-Quality Simulation”
by Grzegorz Łabuz, Weijia Yan, Isabella D. Baur, Ramin Khoramnia and Gerd U. Auffarth
J. Clin. Med. 2023, 12(7), 2523; https://doi.org/10.3390/jcm12072523
Available online: https://www.mdpi.com/2077-0383/12/7/2523
10. “Objective Classification of Glistening in Implanted Intraocular Lenses Using Optical Coherence Tomography: Proposal for a New Classification and Grading System”
by José Ignacio Fernández-Vigo, Bárbara Burgos-Blasco, Lucía De-Pablo-Gómez-de-Liaño, Inés Sánchez-Guillén, Virginia Albitre-Barca, Susana Fernández-Aragón, José Ángel Fernández-Vigo and Ana Macarro-Merino
J. Clin. Med. 2023, 12(6), 2351; https://doi.org/10.3390/jcm12062351
Available online: https://www.mdpi.com/2077-0383/12/6/2351
11. “The Global Burden of Glaucoma: Findings from the Global Burden of Disease 2019 Study and Predictions by Bayesian Age–Period–Cohort Analysis”
by Yi Lin, Bingcai Jiang, Yuanqing Cai, Wangdu Luo, Xiaomin Zhu, Qianyi Lin, Min Tang, Xiangji Li and Lin Xie
J. Clin. Med. 2023, 12(5), 1828; https://doi.org/10.3390/jcm12051828
Available online: https://www.mdpi.com/2077-0383/12/5/1828
12. “Efficacy Evaluation of Tissue Plasminogen Activator with Anti-Vascular Endothelial Growth Factor Drugs for Submacular Hemorrhage Treatment: A Meta-Analysis”
by Xuejun He, Wenye Cao, Zhiyi Wang, Ningzhi Zhang, Kexin Xu, Lu Yu, Yiqiao Xing and Ning Yang
J. Clin. Med. 2023, 12(3), 1035; https://doi.org/10.3390/jcm12031035
Available online: https://www.mdpi.com/2077-0383/12/3/1035
13. “Association between Optic Nerve Sheath Diameter and Lamina Cribrosa Morphology in Normal-Tension Glaucoma”
by Seung Hyen Lee, Tae-Woo Kim, Eun Ji Lee and Hyunkyung Kil
J. Clin. Med. 2023, 12(1), 360; https://doi.org/10.3390/jcm12010360
Available online: https://www.mdpi.com/2077-0383/12/1/360
14. “Effectiveness and Safety of Xen Gel Stent in Glaucoma Surgery: A Systematic Review of the Literature”
by Carlo Enrico Traverso, Roberto G. Carassa, Antonio Maria Fea, Michele Figus, Carlo Astarita, Benedetta Piergentili, Vanessa Vera and Stefano Gandolfi
J. Clin. Med. 2023, 12(16), 5339; https://doi.org/10.3390/jcm12165339
Available online: https://www.mdpi.com/2077-0383/12/16/5339
15. “Long-Term Outcomes of the PRESERFLO MicroShunt Implant in a Heterogeneous Glaucoma Cohort”
by Jens Julian Storp, Friederike Elisabeth Vietmeier, Ralph-Laurent Merté, Raphael Koch, Julian Alexander Zimmermann, Nicole Eter and Viktoria Constanze Brücher
J. Clin. Med. 2023, 12(13), 4474; https://doi.org/10.3390/jcm12134474
Available online: https://www.mdpi.com/2077-0383/12/13/4474
Special Issues |
|
“Refractive Surgery—Where Are We Now?” |
“Multifactorial Causation and Therapies of Myopia” |
|
|
“Advances in Glaucoma Management and Intraocular Pressure Physiology” |
“Advances in the Diagnosis and Management of Age-Related Macular Degeneration” |
|
|
“Diabetic Retinopathy: Current Concepts and Future Directions” |
“Ocular Manifestations of Systemic Diseases” |
|
|
You are invited to view and submit relevant papers to the Journal of Clinical Medicine at the following link: https://www.mdpi.com/journal/jcm.
JCM Editorial Office
29 May 2024
Journal of Clinical Medicine | Highly Cited Papers in 2023 and Hot Topic Special Issues on Cardiology

We are delighted to share some highly cited papers on cardiology that were published in the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) in 2023. In addition, some Special Issues on this topic are currently open for submission.
The following is a list of articles and Special Issues that we believe will interest you:
1. “Stent Thrombosis and Restenosis with Contemporary Drug-Eluting Stents: Predictors and Current Evidence”
by Francesco Condello, Carmen Spaccarotella, Sabato Sorrentino, Ciro Indolfi, Giulio G. Stefanini and Alberto Polimeni
J. Clin. Med. 2023, 12(3), 1238; https://doi.org/10.3390/jcm12031238
Available online: https://www.mdpi.com/2077-0383/12/3/1238
2. “Left Atrial Posterior Wall Isolation with Pulsed Field Ablation in Persistent Atrial Fibrillation”
by Melanie A. Gunawardene, Gerrit Frommeyer, Christian Ellermann, Mario Jularic, Patrick Leitz, Jens Hartmann, Philipp Sebastian Lange, Omar Anwar, Benjamin Rath, Rahin Wahedi et al.
J. Clin. Med. 2023, 12(19), 6304; https://doi.org/10.3390/jcm12196304
Available online: https://www.mdpi.com/2077-0383/12/19/6304
3. “The Global Burden of Valvular Heart Disease: From Clinical Epidemiology to Management”
by Gloria Santangelo, Francesca Bursi, Andrea Faggiano, Silvia Moscardelli, Pasquale Simone Simeoli, Marco Guazzi, Roberto Lorusso, Stefano Carugo and Pompilio Faggiano
J. Clin. Med. 2023, 12(6), 2178; https://doi.org/10.3390/jcm12062178
Available online: https://www.mdpi.com/2077-0383/12/6/2178
4. “TAVI after More Than 20 Years”
by Adriana Postolache, Simona Sperlongano and Patrizio Lancellotti
J. Clin. Med. 2023, 12(17), 5645; https://doi.org/10.3390/jcm12175645
Available online: https://www.mdpi.com/2077-0383/12/17/5645
5. “Myocardial Infarction with Non-Obstructive Coronary Arteries (MINOCA): Focus on Coronary Microvascular Dysfunction and Genetic Susceptibility”
by Paolo Severino, Andrea D’Amato, Silvia Prosperi, Vincenzo Myftari, Lorenzo Colombo, Elisa Tomarelli, Alice Piccialuti, Gianluca Di Pietro, Lucia Ilaria Birtolo, Viviana Maestrini et al.
J. Clin. Med. 2023, 12(10), 3586; https://doi.org/10.3390/jcm12103586
Available online: https://www.mdpi.com/2077-0383/12/10/3586
6. “The Triglyceride–Glucose Index Might Be a Better Indicator for Predicting Poor Cardiovascular Outcomes in Chronic Coronary Syndrome”
by Aslan Erdoğan, Duygu İnan, Ömer Genç, Ufuk Yıldız, Ayşe İrem Demirtola, İlyas Çetin, Yeliz Güler, Ali Fuat Tekin, Süleyman Barutçu, Ahmet Güler et al.
J. Clin. Med. 2023, 12(19), 6201; https://doi.org/10.3390/jcm12196201
Available online: https://www.mdpi.com/2077-0383/12/19/6201
7. “Catheter Ablation for Tachyarrhythmias in Left Ventricular Assist Device Recipients: Clinical Significance and Technical Tips”
by Naoya Kataoka and Teruhiko Imamura
J. Clin. Med. 2023, 12(22), 7111; https://doi.org/10.3390/jcm12227111
Available online: https://www.mdpi.com/2077-0383/12/22/7111
8. “Artificial Intelligence (AI) versus POCUS Expert: A Validation Study of Three Automatic AI-Based, Real-Time, Hemodynamic Echocardiographic Assessment Tools”
by Eyal Gohar, Amit Herling, Mor Mazuz, Gal Tsaban, Tomer Gat, Sergio Kobal and Lior Fuchs
J. Clin. Med. 2023, 12(4), 1352; https://doi.org/10.3390/jcm12041352
Available online: https://www.mdpi.com/2077-0383/12/4/1352
9. “Clinical Usefulness of Right Ventricle–Pulmonary Artery Coupling in Cardiovascular Disease”
by Qing He, Yixia Lin, Ye Zhu, Lang Gao, Mengmeng Ji, Li Zhang, Mingxing Xie and Yuman Li
J. Clin. Med. 2023, 12(7), 2526; https://doi.org/10.3390/jcm12072526
Available online: https://www.mdpi.com/2077-0383/12/7/2526
10. “Heart Failure Pharmacological Management: Gaps and Current Perspectives”
by Paolo Severino, Andrea D'Amato, Silvia Prosperi, Vincenzo Myftari, Elena Sofia Canuti, Aurora Labbro Francia, Claudia Cestiè, Viviana Maestrini, Carlo Lavalle, Roberto Badagliacca et al.
J. Clin. Med. 2023, 12(3), 1020; https://doi.org/10.3390/jcm12031020
Available online: https://www.mdpi.com/2077-0383/12/3/1020
11. “Alcohol Septal Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy: A Contemporary Perspective”
by Felice Gragnano, Francesco Pelliccia, Natale Guarnaccia, Giampaolo Niccoli, Salvatore De Rosa, Raffaele Piccolo, Elisabetta Moscarella, Enrico Fabris, Rocco Antonio Montone, Arturo Cesaro et al.
J. Clin. Med. 2023, 12(8), 2810; https://doi.org/10.3390/jcm12082810
Available online: https://www.mdpi.com/2077-0383/12/8/2810
12. “Neuroimaging Studies of the Neural Correlates of Heart Rate Variability: A Systematic Review”
by Patrycja S. Matusik, Chuwen Zhong, Paweł T. Matusik, Omar Alomar and Phyllis K. Stein
J. Clin. Med. 2023, 12(3), 1016; https://doi.org/10.3390/jcm12031016
Available online: https://www.mdpi.com/2077-0383/12/3/1016
13. “Arrhythmic Manifestations of Cardiac Amyloidosis: Challenges in Risk Stratification and Clinical Management”
by Natallia Laptseva, Valentina A. Rossi, Isabella Sudano, Rahel Schwotzer, Frank Ruschitzka, Andreas J. Flammer and Firat Duru
J. Clin. Med. 2023, 12(7), 2581; https://doi.org/10.3390/jcm12072581
Available online: https://www.mdpi.com/2077-0383/12/7/2581
14. “The Feasibility, Effectiveness and Acceptance of Virtual Visits as Compared to In-Person Visits among Clinical Electrophysiology Patients during the COVID-19 Pandemic”
by Marco Valerio Mariani, Nicola Pierucci, Giovanni Battista Forleo, Marco Schiavone, Alessia Bernardini, Alessio Gasperetti, Gianfranco Mitacchione, Mariachiara Mei, Giuseppe Giunta, Agostino Piro et al.
J. Clin. Med. 2023, 12(2), 620; https://doi.org/10.3390/jcm12020620
Available online: https://www.mdpi.com/2077-0383/12/2/620
15. “Hypertensive Heart Failure”
by Filippos Triposkiadis, Pantelis Sarafidis, Alexandros Briasoulis, Dimitrios E. Magouliotis, Thanos Athanasiou, John Skoularigis and Andrew Xanthopoulos
J. Clin. Med. 2023, 12(15), 5090; https://doi.org/10.3390/jcm12155090
Available online: https://www.mdpi.com/2077-0383/12/15/5090
Special Issues |
|
“Interventional Cardiology: Current Challenges in Clinical Practice” |
“Exercise and Sports Cardiology” |
|
|
“Adult Congenital Heart Disease: An Increasing and Ageing Population: Part II” |
“Clinical Updates in Cardiac Electrophysiology” |
|
|
“Better Management of Heart Failure: Contemporary Strategy and Future Perspective” |
“Clinical Advances in the Diagnosis and Treatment of Atrial Fibrillation” |
|
|
You are invited to view and submit relevant papers to the Journal of Clinical Medicine at the following link: https://www.mdpi.com/journal/jcm.
JCM Editorial Office
23 May 2024
Transfer Service in MDPI
We are pleased to announce MDPI’s Transfer Service.
This service provides a convenient method of transferring your manuscript file, along with any reviewer comments, to another journal within our publishing portfolio.
We are committed to helping authors find the right home for their research, and we will provide authors with guidance and technical support through all stages of the transfer process. Authors will be able to choose to transfer in the following two situations:
1. Select alternative journals on submission.
2. Authors are encouraged to transfer manuscripts to other MDPI journals.
More details about the Transfer Service can be found at the following link:
17 May 2024
Tu Youyou Award—Open for Nominations
In acknowledgment of the groundbreaking achievements of Professor Tu Youyou, the Nobel laureate credited with the discovery of artemisinin, MDPI is proud to announce the Tu Youyou Award. This award, inaugurated in 2016, seeks to honor scholars who excel in the fields of natural products chemistry and medicinal chemistry.
Prize:
- CHF 100,000 in total (If there is more than one winner, the prize will be divided equally amongst the winners);
- An award medal for each winner.
Who should be nominated?
- Scientists with outstanding achievements and contributions in the fields of natural products chemistry and medicinal chemistry.
Who can submit a nomination?
- Academic research institutes
- Universities
- Academic societies
Any personal nominations are not accepted.
How do I submit a nomination?
Candidates’ institutional affiliations need to submit their nominations for final candidates to the Tu Youyou Award Team directly by email after internal screening, and each institution can only nominate a maximum of two candidates for each edition of the Tu Youyou Award. Please note that the nominations cannot be modified once they are submitted and confirmed by the Tu Youyou Award Team.
Required nomination materials:
Nomination Form (Download)
Schedule:
Nomination deadline: 31 December 2024;
Winner announcement: 30 April 2025.
Contact:
Tu Youyou Award Team (tuyouyouaward@mdpi.com)
More information can be found on the Tu Youyou Award official website. For any inquiries, do not hesitate to contact the Tu Youyou Award Team.
16 May 2024
MDPI Romania Author Training Academic Events in April
MDPI Romania sponsored four events over the month of April, contributing author training sessions to each event.
The NutriSciLabs 2024 conference was held at the Carol Davila University of Medicine and Pharmacy on 12 April 2024. Organized by the Association of Students from the Faculty of Pharmacy Studies, the conference aimed to enhance students’ academic writing and research skills, and bolster their confidence in participating in the academic world. Ioana Paunescu, journal relations specialist for MDPI Romania, led the training session. Paunescu first outlined MDPI’s history and core values, then explained academic writing techniques, ethics, and similarity percentages. The presentation covered the entire editorial process, highlighting the amount of attention paid to details throughout manuscript processing. Paunescu also discussed common errors that authors make while writing, and how to avoid such errors.

On 13 April 2024, the NextGEN 2.0 Student Conference took place at the Babes-Bolyai University of Cluj-Napoca. NextGen Healthcare organized this event with the university’s European Students’ Society to discuss European and international current affairs. MDPI Romania contributed an author training session called Steps of the Publication Process. Irina Codruta Zaharia, journal relations specialist, began the session with a general introduction of MDPI before diving into different article types, different layout formats, possible journals to submit to, the MDPI submission checklist, and the MDPI editorial process. By explaining the fundamentals of writing and publishing academic papers, Zaharia imparted valuable industry knowledge to the curious minds present. Participants were eager to engage with Zaharia in the subsequent Q&A session.

Celebrating its 20th anniversary this year, the International Conference “Students for Students” has long been a gathering place for undergraduate and postgraduate students of all nationalities to present their work and exchange ideas with each other. This year’s conference was held on 18 April 2024, with MDPI Romania contributing an author training session called The World of Open Access. Key speakers included Dr. Norbert Kiss from MDPI Romania and Prof. Dragos Horvath from Strasbourg University. Dr. Kiss discussed the history of open access, differences between open access publishing and traditional publishing, and implications for open access in the future. Attendees expressed keen interest in the subject, approaching Dr. Kiss with questions about academic publishing as well as his career trajectory.

Most recently, on 26 April 2024, MDPI Romania sponsored the National Symposium of Students from Geology and Geophysics Faculties. The AAPG Students Chapter at the Babes-Bolyai University organized this event as an opportunity for geology students from all Romanian universities to present their work and confer with other researchers. Dr. Kiss gave his lecture The World of Open Access at this event as well.

MDPI is thankful to all the participants, speakers, and organizers who attended these events. Through their enthusiasm and dedication, these events were great successes.
8 May 2024
Meet Us at the 61st ERA Congress, 23–26 May 2024, Stockholm, Sweden

MDPI will be attending the 61st ERA Congress, which will be held from 23 to 26 May 2024 in Stockholm, Sweden.
The ERA Annual Congress remains committed to advancing the understanding and treatment of kidney disease to improve the well-being of patients. Our aim is to disseminate knowledge with a focus on clinical assessment and treatment, with the overarching theme for this year being “Rethinking Kidney Health and Transforming Kidney Care”. The ERA 2024 will also mark the 60th anniversary of the ERA Registry. Four special sessions (Creative Labs), organized by the ERA Registry group, will provide insight into their expertise and knowledge.
The following MDPI journals will be represented:
If you plan on attending this conference, feel free to stop by our booth. Our delegates look forward to meeting you in person to answer any questions you may have.
For more information about the conference, please visit the following link: https://era-shop.interplan.de/.
2 May 2024
MDPI Insights: The CEO's Letter #11 - 2023 Annual Report, MDPI Awards, STM

Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
2023 Annual Report
This is an exciting time of year at MDPI, as we have just released our annual report 2023, recapping the past year and sharing the progress and changes that took place during it.
Stefan Tochev (CEO, MDPI)
Reflecting on 2023, I can't help but think of the changes that have occurred not only at MDPI but also within our industry as a whole. In light of this, I’m reminded that change is the only constant, and that for a publishing enterprise that has experienced rapid growth, adapting to change becomes not only a necessity but also a catalyst for sustained success.
Looking back on the significant ground we covered in 2023, I am pleased to report that the year was marked by a rise in paper submissions, along with a range of initiatives aimed at improving our internal processes and delivering top services to our scientists.
2023 Top-line MDPI Numbers
An important priority for 2023 was to strengthen our editorial policies. Despite a notable increase in the number of papers submitted from 603,000 to 655,000 (+8.6%), there was a decrease in the number of papers published from 303,000 to 285,000 (-5.9%), consistent with the overall trend in the scholarly publishing market. MDPI’s market share in gold open access articles published reached 17% in 2023 (according to Dimensions data).
2023 Open Access Numbers
For over two decades, MDPI has been at the forefront of reshaping the academic publishing landscape, with OA surpassing subscription-based publishing in 2020. This trajectory is deeply rooted in our history and reflects our unwavering commitment to, and vision for, an open future. This momentum continued in 2023, with 39% of the 4.16 million articles and reviews published as gold full-OA, 15% as gold hybrid-OA, 8% as bronze-OA, and 3% as green-OA, relative to 35% behind a paywall. In terms of gold OA (full or hybrid) articles and reviews published, MDPI leads the way in terms of total articles published in 2023.
MDPI is the trusted and preferred OA publisher for the scholarly community
However, in 2023, we saw a downward trend in publication numbers compared to 2022. This trend was also seen in total OA publications. While the number of submissions increased, the decline in MDPI publications can be attributed to several factors, such as improved scrutiny in our peer-review process, including the evaluation of content scope and higher rejection rates, and a post-pandemic decrease in research related to COVID-19 papers.
Download 2023 MDPI Annual Report.
Access 2023 Digital Report.
Impactful Research
Recognizing Scholars – MDPI Awards
MDPI is committed to empowering young researchers as they embark on their careers. In 2023, our journals hosted a total of 400 awards, receiving 8,839 applications and nominations. The evaluation committees selected 959 winners, with the total budget for these awards amounting to CHF 546,500.
For more information about MDPI awards, applications, and winners, please click here
The following awards recognize scholars and the impact of their research, including Young Investigator Awards, Best PhD Thesis Awards, and Travel Awards for junior researchers.
MDPI Awards – The following awards require an application or a nomination.
Young Investigator Award (CHF 1000–2000 for each winner)
This award acknowledges the achievements of young investigators in research areas relevant to the journal’s scope. Candidates must have received their PhD no more than 10 years prior to the award announcement date and must be nominated.
Best PhD Thesis Award (CHF 500–800 for each winner)
This award recognizes young scholars who have completed outstanding PhD theses in research areas relevant to the journal’s scope. It aims to encourage them to continue their excellent work and make further contributions to their field.
Travel Award (CHF 500–800 for each winner)
This award encourages junior scientists to present their latest research at academic conferences relevant to the journal’s scope, thereby increasing their impact.
Distinguished Scholars
Additionally, 220 awards were granted to the most distinguished authors and reviewers in our journals through Best Paper Awards and Outstanding Reviewer Awards. The following awards are selected by the editorial staff of the journal and do not require an application or a nomination. They exemplify the excellent contributions made by our authors, reviewers, and editors.
These awards exemplify the excellent contributions made by our authors, reviewers, and editors
Best Paper Award (CHF 200–500 for each winner)
This award is granted annually to highlight publications of high quality, scientific significance, and extensive influence.
Outstanding Reviewer Award (CHF 500 for partial winners)
This award is given annually to recognize reviewers who generously contribute their time to reviewing papers and demonstrate thoroughness, professionalism, and timeliness in their reviews.
MDPI also offers awards for specific topics in various research fields:
Carbon Neutrality Award (CHF 500–800 for each winner)
Sponsored by MDPI journal Sustainability, this award recognizes applicants who have made exceptional academic or societal contributions to carbon neutrality, either in general or in relation to a specific carbon-neutrality-related issue.
Intelligent Manufacturing Award (CHF 500–800 for each winner)
Administered by MDPI journal Machines, this award is presented to an individual who has made outstanding academic or societal contributions to the field of intelligent manufacturing.
Granted: World Sustainability Awards
Inside MDPI
MDPI Opens Office in Seoul, Korea and Appoints Claude Seo as Office Manager
As CEO of the world’s leading OA publisher, I am pleased to announce the official opening of our Korean branch office. With this addition, MDPI now operates 21 offices in 12 countries worldwide, improving on our position as a truly global publisher. This expansion represents more than just an increase in our physical footprint; it is a pivotal step in our ongoing commitment to making scientific knowledge more accessible across the globe.
MDPI now operates 21 offices in 12 countries worldwide, improving on our position as a truly global publisher
Claude Seo (MDPI Korea Office Manager, Seoul)
Claude Seo, who has over 15 years of experience in the academic publishing industry, has been appointed as the Office Manager of the Seoul office. The launch of our Seoul office allows us to better support the Korean scientific community and to further promote the publication of OA journals in the region.
Reflecting on his role, Claude shared that he is:
“Delighted to have been entrusted with this position within MDPI, the no. 1 scholarly OA publisher. As we establish our presence in Korea, we are dedicated to integrating ourselves into the local community and contributing to its vibrant culture. Our commitment goes beyond business growth; it is about creating a more informed and innovative society by embracing and promoting diversity within the scientific community.”
Sungkyunkwan University Joins MDPI’s Institutional Open Access Program
Additionally, I am pleased to share that Sungkyunkwan University has joined MDPI’s Institutional Open Access Program (IOAP). This program offers free access to MDP’s online submission system for institutions and provides APC discounts to affiliated authors. Thirteen major Korean universities, including Sungkyunkwan University, Kyunghee University, Chung-Ang University, and the Catholic University of Korea, have adopted IOAP in Korea.
Learn more about MDPI’s collaboration in Korea in my previous CEO Letter, in which I recap our visit to Seoul, South Korea.
Coming Together for Science
4th MMCS: Harnessing the Power of New Drug Modalities
Our conference team successfully managed the 4th Molecules Medicinal Chemistry Symposium, held from 24–26 April in Barcelona, Spain. It was chaired by Prof. Dr. Diego Muñoz-Torrero from the Institute of Biomedicine (IBUB), University of Barcelona, Spain, and Prof. Dr. Simona Collina from the University of Pavia, Italy. In total, there were 84 accepted abstracts and 102 conference attendees from 22 different countries.
From left to right: Prof. Dr. Rino Ragno (Scientific Committee), Dr. Maria Emilia Sousa (Scientific Committee), Prof. Dr. Claudio Viegas Jr. (Scientific Committee), Prof. Dr. Simona Collina (Chair), Prof. Dr. Diego Muñoz-Torrero (Chair), Alvina Wu (Managing Editor, MDPI), Prof. Dr. Roman Dembinski (Scientific Committee), Prof. Dr. Mariana Spetea (Scientific Committee).
The event comprised 12 Invited Speakers, 35 Selected Talks, 10 Flash Poster Presentations, and 39 Posters. The overarching topic of the conference was the impact of the emergence of new drug modalities on drug discovery, with thematic sessions covering topics such as photoactivatable drugs, candidates targeting RNA and epigenetic targets, covalent modifiers, and the development of new anti-cancer agents, among other medicinal chemistry projects.
We are pleased to have received feedback from attendees highlighting the professional approach of the conference chairs and participants, the high quality of the talks, and the overall outstanding organization on the part of the MDPI conference team.
Thank you to the conference sponsors, Fluorochem and IBUB, and to our partnering societies, The Spanish Society for Biochemistry and Molecular Biology (SEBBM), and the Spanish Society of Medicinal Chemistry (SEQT).
Upcoming In-Person Event
28–31 May, 2024
Polymers 2024 – Polymers for a Safe and Sustainable Future
Location: Athens, Greece
Conference Chairs: Prof. Dr. Dimitrios Bikiaris, Prof. Dr. Konstantinos Triantafyllidis, Dr. Ioanna Deligkiozi
We look forward to welcoming experts Prof. Damià Barceló, Prof. Minna Hakkareinen, and Prof. Armando J. D. Silvestre to this event.
Find more upcoming MDPI events here.
Organize Your Event with MDPI’s Sciforum
Sciforum is MDPI’s platform dedicated to the organization of scientific events. In line with our mission to promote science, Sciforum supports scholars, societies, research networks, and universities at all stages of organizing in-person events, virtual events and webinars. Our platforms are efficient, user-friendly, and cost-effective. We handle all steps related to event management. Contact us for details.
Closing Thoughts
A Report from the Future – STM US Annual Conference 2024
Stefan Tochev (CEO, MDPI), Dr. Giulia Stefenelli and Dr. Ioana Craciun from MDPI’s Scientific Office Board.
MDPI has for a long time been a sponsor of the STM Annual Conferences, held yearly in the US and Frankfurt, and is a trusted partner and supporter of the STM organization. While I have attended the Frankfurt conference for the past three years, this was my first time visiting the Washington, DC session, and I am glad I did.
Although it was a brief trip, I greatly appreciated the opportunity to attend in the company of my colleagues Dr. Giulia Stefenelli and Dr. Ioana Craciun from MDPI’s Scientific Office Board. They always help map some of the new industry trends against MDPI’s operational framework and guidelines. It’s a great group for kicking ideas back and forth on what we can apply at MDPI.
In my experience, STM never fails to deliver. It’s always a great conference for reconnecting with fellow publishers, industry friends, and vendors. As usual, STM this year curated a diverse range of speakers and panels, who proferred valuable knowledge and insights from outside our industry, delivering thought-provoking insights into our field. An example of this was the ‘Trust Panel’ session, which included Alan Schiffres (Managing Director, InfoLinx), who shared a number of the learnings about fraud and risk management from his 40 years in financial services, to help address some of the challenges we are currently facing in the area of publishing integrity.
Launch of STM Trends 2028 Panel
I particularly enjoyed the ‘Launch of STM Trends 2028 Panel’, which presented a report focused on the integration of humans and machines in scholarly publishing. The session highlighted themes such as AI, digitization, and the evolving research ecosystem. The report envisions a future where technology blurs the lines between human and machine involvement in research processes, with significant implications for trust, reputation, and equity. While this presents opportunities for connectivity and knowledge dissemination, it also poses challenges such as disinformation, fragmentation, and geopolitical tensions. We must rely on a wise combination of technology and human agency to navigate this complex landscape and will have to carefully examine its potential impacts on communication and scholarly publishing.
MDPI has joined the STM Integrity Hub. Click here to learn more.
While every presenter brought their own knowledge and personal touch, I was particularly pleased to encounter new speakers such as Heather Whitney (Research Assistant Professor, Radiology, University of Chicago) and Igor Grossmann (Professor of Psychology, University of Waterloo, Canada). Having studied Sociology at the University of Guelph, I have a soft spot for fellow social scientists from Canada, and I was very impressed by Igor’s presentation on ‘The Social Scientist: A View from the Future’ and his participation in the panel session ‘The Future Beyond the Article,’ which was one of my favourites from the conference, given the diversity of perspectives from the panel speakers.
Memorial Park in Washington, DC
On a personal note, this was my first-time visiting Washington, DC, and I’m glad we took an afternoon to visit the Memorial Park, with its incredible monuments to figures ranging from Martin Luther King, Jr. to Abraham Lincoln. The magnitude of the monuments is deeply impressive. I particularly appreciated the Thomas Jefferson memorial and the following quote, which I think speaks to the importance of change and adaptation. It’s something we can apply not only in our industry but also in our personal lives.
"I am not an advocate for frequent changes in laws and constitutions, but laws and institutions must go hand in hand with the progress of the human mind. As that becomes more developed, more enlightened, as new discoveries are made, new truths discovered and manners and opinions change, with the change of circumstances, institutions must advance also to keep pace with the times. We might as well require a man to wear still the coat which fitted him when a boy as a civilized society to remain ever under the regimen of their barbarous ancestors."
– Excerpted from a letter to Samuel Kercheval, July 12, 1816.
Chief Executive Officer
MDPI AG
30 April 2024
Journal of Clinical Medicine 2024 Editorial Board Meeting of the Section “Epidemiology & Public Health” Held on 6 March 2024

The Journal of Clinical Medicine (JCM, ISSN: 2077-0383) held an Editorial Board meeting for the Section “Epidemiology & Public Health” on 6 March 2024. We appreciate the Section Editor-in-Chief, Prof. Dr. Francisco Guillen-Grima, for hosting this meeting; four Editorial Board Members were in attendance.
The meeting started with a presentation about the development of the journal as well as the Section “Epidemiology & Public Health”, with the following information being presented:
- Journal history, publication statistics, distribution of scholars (2018–2023), the benefits of open access, journal awards, conference sponsorship, and promotion on social media;
- Geographical distribution of the Section’s Editorial Board Members, decision-making statistics, and Section statistics.
The meeting mainly discussed the Section scope, popular topics (such as AI and machine learning in medicine), feature paper contributions and invitations by the Editorial Board Members, the direction of article types, social media promotion, and conference suggestions.
Based on the discussion, the journal plans to update the Section webpage (in progress), fortify feature paper contributions from the Editorial Board Members, keep an eye on popular topics and research fronts, be more present at conferences (such as the European Public Health Association Conference, etc.), and try different social media platforms (YouTube, etc.) to strengthen journal promotion.
We thank every Editorial Board Member and the academics for their support. We look forward to receiving more suggestions to continue our progress together.
Attendee list (in no particular order):
- Prof. Dr. Francisco Guillen-Grima (Section Editor-in-Chief), University of Navarra, Pamplona, Spain;
- Dr. Giampiero Mazzaglia, University of Milan-Bicocca, 20900 Monza, Italy;
- Prof. Dr. Gabriel Chodick, Tel-Aviv University, Tel-Aviv, Israel;
- Prof. Dr. Frank Klawonn, Ostfalia University of Applied Sciences, Wolfenbuettel, Germany;
- Prof. Dr. Eleni Jelastopulu, University of Patras, University Campus, Rio, Greece.
The latest official CiteScore (2022 Scopus data) for the Journal of Clinical Medicine is 5.4, ranking 137/830 (Q1) in the “General Medicine” category. The current Impact Factor of JCM is 3.9 (2022), ranking 58/167 (Q2) in the “Medicine, General & Internal” category.
To access more journal statistics, please click here.
To access more information about the Section, please visit the following link: https://www.mdpi.com/journal/jcm/sections/Epidemiology_Public_Health.
30 April 2024
Journal of Clinical Medicine 2024 Editorial Board Meeting of the Section “Gastroenterology & Hepatopancreatobiliary Medicine” Held on 1 March 2024

The Journal of Clinical Medicine (JCM, ISSN: 2077-0383) held an Editorial Board Meeting for the Section “Gastroenterology & Hepatopancreatobiliary Medicine” on 1 March 2024. Professor Doctor Hidekazu Suzuki, the Section Editor-in-Chief, had an engaging conversation with the Editorial Board Members Professor Doctor Pieter Hindryckx, Professor Doctor Stephen Riordan, and the journal relations team.
The meeting started with a presentation about the development of the journal, as well as the Section “Gastroenterology & Hepatopancreatobiliary Medicine”, with the following information being presented:
- The journal’s history, publication statistics, distribution of scholars (2018–2023), the benefits of open access, journal awards, conference sponsorship, and promotion on social media;
- The geographical distribution of the Section’s Editorial Board Members, decision-making statistics, and Section statistics.
The meeting chaired by Professor Doctor Suzuki mainly addressed the following points:
- The Impact Factor and citations of the Section and the journal;
- Article type: in addition to original articles, comprehensive review papers and guidelines will be encouraged. Excellent case reports on rare diseases and papers with videos or high-quality tables/figures will also be considered for submission;
- Hot topics: recommendations by Editorial Board Members within the Section, such as AI and its application in inflammatory bowel disease (IBD), endoscopy, etc.;
- Manuscript processing: papers’ topic distribution, paper lengths, the reviewer database, reviewer vouchers, acceptance/rejection rates;
- Journal promotion: we discussed enhancing the journal’s advertising and describing author benefits in social media posts;
- Conferences/meetings: enriching of the geographical distribution of our conferences, the proposal of an offline board meeting, and suggestions for the board’s meeting frequency (quarterly or half yearly).
We would like to thank every Editorial Board Member and contributing academics for their support. We look forward to receiving more suggestions so that we can continue our progress together.
Attendee list (in no particular order):
- Prof. Dr. Hidekazu Suzuki (Section Editor-in-Chief), Tokai University School of Medicine, Kanagawa, Japan;
- Prof. Dr. Pieter Hindryckx, Ghent University, Ghent, Belgium;
- Prof. Dr. Stephen Riordan, University of New South Wales, Sydney, Australia.
Due to time-zone differences, some Editorial Board Members were unable to attend this meeting.
The latest official CiteScore (2022 Scopus data) for the Journal of Clinical Medicine is 5.4, ranking 137/830 (Q1) in the “General Medicine” category. The current Impact Factor of JCM is 3.9 (2022), ranking 58/167 (Q2) in the “Medicine, General & Internal” category.
To access more journal statistics, please click here.
To find out more information about the Section, please visit the following link: https://www.mdpi.com/journal/jcm/sections/Gastroenterology_Hepatology.